MTOR and cancer: Similarly, Bacteroides fragilis-associated lncRNA1 (BFAL1), participating in gut bacteria-induced carcinogenesis, was found to bind to miR-200a in a competitive manner, activating the MTORC1 binding/mammalian target of the rapamycin (RHEB/mTOR) pathway, which is commonly dysregulated in cancer [102].